Jump to navigation

Home

AAAAI Education Center

Open menu
Cart
  • Log in

Bookmark/Search this post

  • Facebook logo Facebook
  • Twitter logo Twitter
  • LinkedIn logo LinkedIn
  • Forward logo Forward

Add to favorites link

Add to favorites...

  • Educational Opportunities
    • AAAAI Webinars
    • Allied Health Education
    • RSL Society CME
    • Other A/I Education
    • Teaching Slides
  • CME/CE Tools & Resources
    • CME Application
    • Online Learning Activity Proposal
    • Survey Request Form
    • Activity Endorsement Application
    • AAAAI Accreditations
    • Education Policies
    • Disclosure Policy
  • Leadership & Training
    • Medical Educators
    • AAAAI Program Directors Assembly Toolbox
  • Help Center
    • Login Instructions
    • Locating Activities
    • Resuming an Incomplete Activity
    • Registering for an Activity
    • Accessing the Virtual Annual Meeting
    • Claiming Credits
    • CME/CE Certificates
    • Receipt/Invoice
    • Contact Us

You are here

Home

Vaccine Distribution

  • The CDC updates the number of COVID-19 vaccines distributed and administered. Numbers are available for both individual states and nationally. 
  • FDA continues to strongly recommend that health care providers follow the FDA-authorized dosing schedule for each COVID-19 vaccine. 
  • Your state public health department website is the best source of information for how to obtain the vaccine and when doses are expected to be available.
  • Who will receive the vaccine first? The National Academy of Sciences (NAS) issued a framework for the equitable allocation of the vaccine (October 2, 2020) and the Advisory Committee on Immunization Practices (ACIP) provided similar guidance (November 23, 2020).
    • During their meeting on December 1, the ACIP recommended that healthcare providers and long-term care residents be included in phase 1A of vaccine distribution.
    • During a December 20 meeting, the ACIP recommended that adults age 75 and older and front line essential workers be included in phase 1B of vaccine distribution. Adults age 65-74 and individuals aged 16-64 with high risk medical conditions are included in phase 1C.
    • Vaccine allocation is determined by the states, and while the ACIP recommendations are not binding it is expected they will guide state’s decisions.

Features

  • Home

Medical content developed and reviewed by the leading experts in allergy, asthma and immunology. 
© 2020 American Academy of Allergy, Asthma & Immunology. All Rights Reserved. | Legal Notices | Site Map | Contact Us

Powered by the EthosCE Learning Management System, a continuing education LMS.
      • Educational Opportunities
        • AAAAI Webinars
        • Allied Health Education
        • RSL Society CME
        • Other A/I Education
        • Teaching Slides
      • CME/CE Tools & Resources
        • CME Application
        • Online Learning Activity Proposal
        • Survey Request Form
        • Activity Endorsement Application
        • AAAAI Accreditations
        • Education Policies
        • Disclosure Policy
      • Leadership & Training
        • Medical Educators
        • AAAAI Program Directors Assembly Toolbox
      • Help Center
        • Login Instructions
        • Locating Activities
        • Resuming an Incomplete Activity
        • Registering for an Activity
        • Accessing the Virtual Annual Meeting
        • Claiming Credits
        • CME/CE Certificates
        • Receipt/Invoice
        • Contact Us